Cellectar Biosciences, Inc.

CLRB·NASDAQ·$3.10Share Price as of 11/2·$10MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-K/AFY 202504/30/26 10-KFY 202503/04/26 10-QQ3 ended 09/30/2511/13/25

Disclosures

8-KCurrent report08/13/26 8-KCurrent report07/10/26 8-KCurrent report05/18/26 8-KCurrent report05/14/26 8-KCurrent report05/08/26

Prospectuses and Registrations

424B3Prospectus06/02/26 S-1/ARegistration statement (amended)05/29/26 S-1Registration statement (IPO)05/19/26 424B5Prospectus supplement05/06/26 424B3Prospectus11/21/25

Proxies

DEF 14ADefinitive proxy05/28/26 DEFA14AAdditional proxy materials05/28/26 PRE 14APreliminary proxy05/18/26 DEFA14AAdditional proxy materials06/11/25 DEF 14ADefinitive proxy04/28/25

Ownership

SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/13/26

Other

EFFECTRequest for effectiveness06/01/26 CORRESPCorrespondence with the SEC05/29/26 UPLOADLetter from the SEC05/22/26 EFFECTRequest for effectiveness07/01/25 CORRESPCorrespondence with the SEC06/30/25